Jump to main content

yr 〜
yr

Search results 3

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation
Digital博士論文障害者向け資料あり
島松, 淳一郎2020-03-01
National Diet Library
  • Subject HeadingClopidogrel Drug change Genetic polymorph...

脳梗塞または一過性脳虚血発作患者におけるP2Y12受容体阻害薬のPAR1，PAR4凝集抑制効果

脳梗塞または一過性脳虚血発作患者におけるP2Y12受容体阻害薬のPAR1，PAR4凝集抑制効果
Digital博士論文障害者向け資料あり
鎌田, 麻美ELSEVIER2021-03
National Diet Library
  • Subject HeadingStroke—Platelet aggregation—PAR4—PAR1—P2Y12 receptor antagonist—Clopidogrel

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation
Digital博士論文
島松, 淳一郎
Available onlineOther Libraries in Japan
  • Subject HeadingClopidogrel Drug change Genetic polymorph...

Reached to the end of result.

RSS